These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 35108063)
1. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease. Bertoglio D; Bard J; Hessmann M; Liu L; Gärtner A; De Lombaerde S; Huscher B; Zajicek F; Miranda A; Peters F; Herrmann F; Schaertl S; Vasilkovska T; Brown CJ; Johnson PD; Prime ME; Mills MR; Van der Linden A; Mrzljak L; Khetarpal V; Wang Y; Marchionini DM; Skinbjerg M; Verhaeghe J; Dominguez C; Staelens S; Munoz-Sanjuan I Sci Transl Med; 2022 Feb; 14(630):eabm3682. PubMed ID: 35108063 [TBL] [Abstract][Full Text] [Related]
2. In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using Bertoglio D; Weiss AR; Liguore W; Martin LD; Hobbs T; Templon J; Srinivasan S; Dominguez C; Munoz-Sanjuan I; Khetarpal V; Verhaeghe J; Staelens S; Link J; Liu L; Bard JA; McBride JL J Nucl Med; 2023 Oct; 64(10):1581-1587. PubMed ID: 37591545 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates. Herrmann F; Hessmann M; Schaertl S; Berg-Rosseburg K; Brown CJ; Bursow G; Chiki A; Ebneth A; Gehrmann M; Hoeschen N; Hotze M; Jahn S; Johnson PD; Khetarpal V; Kiselyov A; Kottig K; Ladewig S; Lashuel H; Letschert S; Mills MR; Petersen K; Prime ME; Scheich C; Schmiedel G; Wityak J; Liu L; Dominguez C; Muñoz-Sanjuán I; Bard JA Sci Rep; 2021 Sep; 11(1):17977. PubMed ID: 34504195 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice. Caron NS; Banos R; Aly AE; Xie Y; Ko S; Potluri N; Anderson C; Black HF; Anderson LM; Gordon B; Southwell AL; Hayden MR Neurobiol Dis; 2022 May; 166():105652. PubMed ID: 35143966 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy. Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189 [TBL] [Abstract][Full Text] [Related]
7. PET Ligands for Imaging Mutant Huntingtin Aggregates: A Case Study in Non-For-Profit Scientific Management. Dickmann CGF; Milicevic Sephton S; Barker RA; Aigbirhio FI Chembiochem; 2024 Jun; 25(11):e202400152. PubMed ID: 38695673 [TBL] [Abstract][Full Text] [Related]
8. Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease. Wang N; Gray M; Lu XH; Cantle JP; Holley SM; Greiner E; Gu X; Shirasaki D; Cepeda C; Li Y; Dong H; Levine MS; Yang XW Nat Med; 2014 May; 20(5):536-41. PubMed ID: 24784230 [TBL] [Abstract][Full Text] [Related]
10. Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand. Liu L; Prime ME; Lee MR; Khetarpal V; Brown CJ; Johnson PD; Miranda-Azpiazu P; Chen X; Clark-Frew D; Coe S; Davis R; Dickie A; Ebneth A; Esposito S; Gadouleau E; Gai X; Galan S; Green S; Greenaway C; Giles P; Halldin C; Hayes S; Herbst T; Herrmann F; Heßmann M; Jia Z; Kiselyov A; Kotey A; Krulle T; Mangette JE; Marston RW; Menta S; Mills MR; Monteagudo E; Nag S; Nibbio M; Orsatti L; Schaertl S; Scheich C; Sproston J; Stepanov V; Svedberg M; Takano A; Taylor M; Thomas W; Toth M; Vaidya D; Vanräs K; Weddell D; Wigginton I; Wityak J; Mrzljak L; Munoz-Sanjuan I; Bard JA; Dominguez C J Med Chem; 2020 Aug; 63(15):8608-8633. PubMed ID: 32662649 [TBL] [Abstract][Full Text] [Related]
11. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice. Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effects of σ Jin J; Arbez N; Sahn JJ; Lu Y; Linkens KT; Hodges TR; Tang A; Wiseman R; Martin SF; Ross CA ACS Chem Neurosci; 2022 Oct; 13(19):2852-2862. PubMed ID: 36108101 [TBL] [Abstract][Full Text] [Related]
13. Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model. Shing K; Sapp E; Boudi A; Liu S; Seeley C; Marchionini D; DiFiglia M; Kegel-Gleason KB Neurobiol Dis; 2023 Oct; 187():106313. PubMed ID: 37777020 [TBL] [Abstract][Full Text] [Related]
14. Bim contributes to the progression of Huntington's disease-associated phenotypes. Roberts SL; Evans T; Yang Y; Fu Y; Button RW; Sipthorpe RJ; Cowan K; Valionyte E; Anichtchik O; Li H; Lu B; Luo S Hum Mol Genet; 2020 Jan; 29(2):216-227. PubMed ID: 31813995 [TBL] [Abstract][Full Text] [Related]